Solulink

About:

SoluLink provides linking reagents, conjugation kits and services for life science research, diagnostics, and pharmaceutical markets.

Website: http://solulink.com

Twitter/X: Solulink

Top Investors: Tech Coast Angels

Description:

SoluLinK, Inc. provides linking reagents, conjugation kits, and conjugation services for life science research, diagnostics, and pharmaceutical markets. It offers biotin and digoxigenin labeling, magnetic beads and agarose, biotin and streptavidin, antibody labeling, antibody-oligo labeling, peptide linking and synthesis, and crosslinking products, as well as accessories. The company’s products are used in antibody, nanolink streptavidin magnetic beads, peptide conjugates, protein-peptide conjugates, solid phase peptide immobilization, streptavidin, protein conjugation kits, better biotin, and peplink linkable peptides applications. It offers its products through distributors and licensing partners in Australia, Austria, Belgium, Canada, China, the Czech Republic, Denmark, Finland, France, Germany, India, Ireland, Israel, Italy, Japan, South Korea, the Netherlands, Portugal, the Russian Federation, Singapore, Spain, Sweden, Switzerland, Taiwan, the United Kingdom, and the United States. SoluLinK, Inc. was incorporated in 2000 and is based in San Diego, California.

Total Funding Amount:

$2.89M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2000-01-01

Contact Email:

info(AT)solulink.com

Founders:

David Schwartz

Number of Employees:

11-50

Last Funding Date:

2013-12-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai